Nephros, Inc.
NEPH
$3.58
$0.113.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.21M | 4.73M | 4.76M | 4.42M | 4.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.21M | 4.73M | 4.76M | 4.42M | 4.88M |
| Cost of Revenue | 2.22M | 1.97M | 1.85M | 1.62M | 1.72M |
| Gross Profit | 2.99M | 2.76M | 2.92M | 2.80M | 3.15M |
| SG&A Expenses | 2.52M | 2.32M | 2.23M | 2.20M | 2.25M |
| Depreciation & Amortization | 29.00K | 32.00K | 34.00K | 35.00K | 39.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.12M | 4.71M | 4.45M | 4.17M | 4.31M |
| Operating Income | 97.00K | 18.00K | 314.00K | 248.00K | 566.00K |
| Income Before Tax | 140.00K | 62.00K | 340.00K | 246.00K | 558.00K |
| Income Tax Expenses | -- | 0.00 | 3.00K | 9.00K | -- |
| Earnings from Continuing Operations | 140.00K | 62.00K | 337.00K | 237.00K | 558.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 140.00K | 62.00K | 337.00K | 237.00K | 558.00K |
| EBIT | 97.00K | 18.00K | 314.00K | 248.00K | 566.00K |
| EBITDA | 124.00K | 50.00K | 348.00K | 281.00K | 606.00K |
| EPS Basic | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.02 | 0.01 | 0.03 |
| EPS Diluted | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.02 | 0.01 | 0.03 |
| Average Basic Shares Outstanding | 10.65M | 10.65M | 10.61M | 10.60M | 10.60M |
| Average Diluted Shares Outstanding | 10.99M | 11.21M | 11.04M | 10.81M | 10.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |